Loading...
GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
Despite escalating methamphetamine use and high relapse rates, pharmacotherapeutics for methamphetamine use disorders are not available. Our iterative drug discovery program had found that R-N-(1,2-dihydroxypropyl)-2,6-cis-di-(4-methoxyphenethyl)piperidine hydrochloride (GZ-793A), a selective vesicu...
Na minha lista:
| Udgivet i: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863457/ https://ncbi.nlm.nih.gov/pubmed/31413138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.119.258699 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|